Home / Stocks / GENPHARMA
Back to all stocks
BSE · GENPHARMA

GENPHARMASEC LIMITED (GENPHARMA) Share Price

Sector: Healthcare · ISIN: INE861N01036

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,350
of 5,047 stocks
▼ 291W▼ 81M
Peak #3,260 · 21 Sep 2026

GENPHARMASEC LIMITED, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap
59.80 Cr
P/E Ratio
108.00
P/B Ratio
0.91
ROE
0.85%
ROCE
2.43%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue85.66 Cr49.71 Cr55.43 Cr39.83 Cr
Net Profit1.03 Cr-17.38 L1.35 Cr-83.20 L
EPS0.010.000.020.02
Operating Profit2.02 Cr65.67 L2.33 Cr-92.09 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
29.98%
Public
70.02%

PUBLIC BREAKDOWN

Individuals
63.53%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
09 Jan 2024OtherRight Issue of Equity Shares
25 May 2023OtherE.G.M.
11 Apr 2019SplitStock Split From Rs.10/- to Rs.1/-
03 Aug 2016OtherReduction of Capital

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs